The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population

BACKGROUND: Fingolimod (FTY-720) has shown efficacy in relapsing multiple sclerosis (MS), while some side effects of this drug have been recognized that the most important is cardiovascular side effects. The aim of this study was to evaluate the cardiovascular side effects of FTY-720. However, the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdar, Morteza, Ebrahimifar, Payam, Etemadifar, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455326/
https://www.ncbi.nlm.nih.gov/pubmed/28607567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455326/
https://www.ncbi.nlm.nih.gov/pubmed/28607567

Ejemplares similares